(Press-News.org) A pigment that makes feathers and hair orange helps prevent cellular damage by removing excess cysteine from cells. Pheomelanin is an orange-to-red pigment that is built with the amino acid cysteine and found in human red hair and fair skin, as well as in bird feathers. Previous research has shown that pheomelanin is associated with increased melanoma risk, raising questions about why evolution has maintained genetic variants that promote pheomelanin production. Ismael Galván and colleagues studied 65 adult zebra finches divided into treatment and control groups. In the treatment group, male zebra finches received dietary cysteine and ML349, a drug that blocks pheomelanin synthesis. Male birds treated with both cysteine and ML349 showed increased oxidative damage in blood plasma compared to males receiving only cysteine, when the authors controlled for overall expression of the regulator of antioxidants by melanocytes. Female birds, which do not produce pheomelanin, tended to show increased oxidative damage when treated with cysteine alone as compared to female controls. According to the authors, pheomelanin synthesis helps maintain cysteine homeostasis by converting excess cysteine into inert pigment, which may explain why pheomelanin-promoting genetic variants persist despite being associated with increased melanoma risk.
END
A role for orange pigments in birds and human redheads
2026-01-06
ELSE PRESS RELEASES FROM THIS DATE:
Pathways to net-zero greenhouse gas emissions for Southeast Asia
2026-01-06
Could Southeast Asia become carbon neutral by 2050, even as energy demand increases? The region is growing quickly and still relies heavily on fossil fuels. A modeling study by Bin Su and colleagues provides an energy system optimization model with pathways to net-zero emissions by 2050 for the electricity and hydrogen sectors in members of the Association of Southeast Asian Nations (ASEAN): Indonesia, Malaysia, Philippines, Singapore, Thailand, Brunei, Vietnam, Lao PDR, Myanmar, and Cambodia. The model simulates energy production and demand ...
A JBNU–KIMS collaborative study on a cost-effective alloy matches superalloys for power plants and energy infrastructure
2026-01-06
The emergence of carbon-neutral energy systems such as high-temperature electrolysis, solar thermal power plants, small modular reactors, and hydrogen- and ammonia-based processes has necessitated the development of novel structural materials that exhibit outstanding corrosion resistance and mechanical properties even at high temperatures and under harsh environments. Notably, traditional austenitic stainless steels (ASSs) fail in these conditions. Addressing this technological gap, materials science engineers have come up with Ni- and Fe-based ...
New study overturns long-held model of how plants coordinate immune responses.
2026-01-06
University of Warwick researchers discover rapid, jasmonate-driven, early immune response in plants using breakthrough live-imaging tool.
Plants mobilise their immune defences far earlier than scientists have believed for decades — and through a previously overlooked early signalling mechanism - according to a new study published in Nature Plants.
Unlike animals, plants are literally rooted to the spot and cannot deploy specialised immune cells or antibodies, nor run away. Instead, every cell must be capable of responding to attack from pathogenic viruses, bacteria, fungi, or insect pests. When attacked plants quickly initiate defence responses ...
New AI model predicts disease risk while you sleep
2026-01-06
A poor night’s sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road. A new artificial intelligence model developed by Stanford Medicine researchers and their colleagues can use physiological recordings from one night’s sleep to predict a person’s risk of developing more than 100 health conditions.
Known as SleepFM, the model was trained on nearly 600,000 hours of sleep data collected from 65,000 participants. The sleep data comes ...
Scientists discover molecular ‘reshuffle’ and crack an 80-year-old conundrum
2026-01-06
Researchers at the University of St Andrews have uncovered a long‑elusive molecular ‘reshuffle', a breakthrough that tackles one of chemistry’s most persistent challenges and could transform the way medicines are manufactured.
In a paper published today (6th January) in Nature Chemistry, researchers from the School of Chemistry have found a key to unlocking an 80-year-old chemical puzzle, which could have important ramifications for fine chemical processes like those involved in the manufacture of medicines.
Chiral molecules are asymmetric or non-superimposable on their mirror image. Each side is different, existing in “right hand” ...
How stressors during pregnancy impact the developing fetal brain
2026-01-06
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in the mother’s immune system have been linked to an increased risk of neurodevelopmental disorders in children. A new study, published today in Nature Neuroscience, expands our understanding of this “gut-immune axis” by mapping the impact of stressors during pregnancy – namely changes in the microbiome and activation of the immune system - on the neuroimmune landscape of the developing fetal brain.
The research team, led by ...
Electrons lag behind the nucleus
2026-01-06
One of the great successes of 20th-century physics was the quantum mechanical description of solids. This allowed scientists to understand for the first time how and why certain materials conduct electric current and how these properties could be purposefully modified. For instance, semiconductors such as silicon could be used to produce transistors, which revolutionized electronics and made modern computers possible.
To be able to mathematically capture the complex interplay between electrons and atomic nuclei and their motions in a solid, physicists ...
From fungi to brain cells: one scientist's winding path reveals how epigenomics shapes neural destiny
2026-01-06
LA JOLLA, California, USA, 6 January 2026 -- In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple disciplines before arriving at fundamental questions about how the brain develops and what goes wrong in psychiatric disorders. Her work now stands at the forefront of international efforts to decode the molecular signatures that define every cell type in the human brain.
Dr. Behrens serves as a faculty member in the Computational Neurobiology Laboratory at the Salk Institute for Biological Studies and holds ...
Schizophrenia and osteoporosis share 195 genetic loci, highlighting unexpected biological bridges between brain and bone
2026-01-06
TIANJIN, CHINA, 6 January 2026 -- A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered striking molecular connections between schizophrenia and bone health, identifying 195 shared genetic loci that may explain why psychiatric patients face elevated fracture risks. The peer-reviewed research, published in Genomic Psychiatry, analyzed genomic data from over half a million individuals and reveals that these two seemingly unrelated conditions suggest overlapping biological pathways at the molecular level.
The finding carries immediate clinical weight. Patients with schizophrenia experience osteoporosis at rates far ...
Schizophrenia-linked genetic variant renders key brain receptor completely unresponsive to both natural and therapeutic compounds
2026-01-06
ADELAIDE, South Australia, AUSTRALIA, 6 January 2026 -- A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely silence a brain receptor that pharmaceutical companies are racing to target with new drugs. Researchers at Flinders University, publishing their peer-reviewed findings in Genomic Psychiatry, demonstrate that this single amino acid change transforms the trace amine-associated receptor 1 (TAAR1) from a functioning cellular gatekeeper into a molecular dead end.
The discovery carries weight far beyond basic science. Several drug companies have invested heavily in TAAR1-targeting medications, ...